Skip to main content
Signal8
DORMAN STUART profile photo

Stuart Dorman

CIK: 0002047580

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IDEAYA Biosciences, Inc. logo
IDYA

IDEAYA Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • IDEAYA Biosciences, Inc. logo
    IDYA

    IDEAYA Biosciences, Inc.

    Jan 30, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    155K shares-
  • IDEAYA Biosciences, Inc. logo
    IDYA

    IDEAYA Biosciences, Inc.

    Feb 27, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    15K shares-

1-2 of 2

About DORMAN STUART

DORMAN STUART (SEC CIK 0002047580) files insider reports with the SEC as Chief Commercial Officer of IDEAYA Biosciences, Inc. (IDYA).

Signal8 holds 3 ownership filings by DORMAN STUART (1 Form 3, 2 Form 4), filed between Dec 20, 2024 and Feb 2, 2026. Those filings report 2 transactions, from Feb 27, 2025 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DORMAN STUART's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by DORMAN STUART

  • Jan 30, 2026: Grant or award of IDYA derivative securities (Form 4, code A).
  • Feb 27, 2025: Grant or award of IDYA derivative securities (Form 4, code A).

Other insiders filing for IDEAYA Biosciences, Inc. (IDYA)

How to read Form 4 transaction codes